TREA

88534786 - SPOROLIFE

Follow

Information

  • Trademark
  • 88534786
  • Serial Number
    88534786
  • Registration Number
    5982682
  • Filing Date
    July 25, 2019
    5 years ago
  • Registration Date
    February 11, 2020
    5 years ago
  • Transaction Date
    March 05, 2025
    18 days ago
  • Status Date
    February 11, 2020
    5 years ago
  • Published for Opposition Date
    November 26, 2019
    5 years ago
  • Location Date
    March 03, 2025
    20 days ago
  • First Use Anywhere Date
    January 05, 2017
    8 years ago
  • First Use In Commerce Date
    January 05, 2017
    8 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    JOHNSON II, COLLIER
  • Attorney Docket Number
    4397.02-012
    Attorney Name
    Joseph A. Mandour
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SPOROLIFE
Case File Statements
  • GS0051: Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs
Case File Event Statements
  • 7/29/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 11/6/2019 - 5 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/2/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/17/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/24/2019 - 5 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/26/2019 - 5 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/26/2019 - 5 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/11/2020 - 5 years ago
    8 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/11/2025 - a month ago
    9 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 2/12/2025 - a month ago
    10 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 3/3/2025 - 20 days ago
    11 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/5/2025 - 18 days ago
    13 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 3/4/2025 - 19 days ago
    12 - OFFICE ACTION ISSUED POU1 Type: PUM1